Development of Biomarkers for Inhibition of SLC6A19 (B0AT1)-A Potential Target to Treat Metabolic Disorders

Citation

Javed, K, Cheng, Q, Carroll, A et al 2018, 'Development of Biomarkers for Inhibition of SLC6A19 (B0AT1)-A Potential Target to Treat Metabolic Disorders', International Journal of Molecular Sciences, vol. 19, no. 11, pp. 22pp.

Year

2018

Field of Research

  • Biochemistry And Cell Biology Not Elsewhere Classified

Updated:  08 December 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers